Fluconazole* (Diflucan) GENERIC DRUGS Itraconazole* (Sporanox) Ascension Health endorses the use of FDA Ketoconazole* (Nizoral) Nystatin* (Mycostatin) encourages the prescribing and dispensing of Terbinafine* (Lamisil) (QL) these generic medications whenever medically ANTI-MALARIALS ____________________________ Chloroquine* (Aralen) EXCLUDED DRUGS Hydroxy
Clipperdistribution.infoMATERIAL SAFETY DATA SHEET
SECTION 1 - IDENTIFICATION OF PRODUCT AND COMPANY
Pfizer Animal Health
Hours of operation
235 East 42nd Street
New York, NY 10017
Clavamox ® Tablets
Clavamox ® Tablets
Amoxicillin tablets supplied in strip packs SECTION 2 - COMPOSITION
Ingredient(s) indicated as hazardous have been assessed under standardsfor workplace safety.
SECTION 3 - HAZARDS IDENTIFICATION
Statements of hazard
MAY CAUSE SENSITIZATION BY INHALATION AND SKIN
None known; however, direct contact with any foreign material may causeeye irritation.
Allergic skin reactions might occur following direct contact with thismaterial.
Not expected due to physical form. Repeated exposure to dust or mist mayproduce allergic reactions.
May cause allergic reaction in penicillin-sensitive individuals.
Known clinical effects
Individuals who are allergic to penicillin antibiotics might exhibit allergicreactions, possibly severe. SECTION 3 - HAZARDS IDENTIFICATION . continued
This document has been prepared in accordance with standards forworkplace safety, which require the inclusion of all known hazards of theproduct or its ingredients regardless of the potential risk. Theprecautionary statements and warnings included may not apply in allcases. Your needs may vary depending upon the potential for exposure inyour workplace.
SECTION 4 - FIRST AID MEASURES
Remove contaminated clothing and flush exposed area with water. Obtainmedical assistance if irritation occurs, which may be delayed. Immediately flush eyes with water for at least 15 minutes. If irritationoccurs or persists, get medical attention. Inhalation
Remove to fresh air. If not breathing, give artificial respiration. Ifdiscomfort persists, get medical attention.
SECTION 5 - FIRE FIGHTING MEASURES
This material is not expected to support combustion. Toxic or corrosivegases are expected during a fire or heating of this material. Fire fighting instructions
Wear approved positive pressure, self-contained breathing apparatus andfull protective turn out gear. Move containers from fire area if possiblewithout increased personal risk. Dike area if possible to contain water forlater disposal. Extinguishing media
Use carbon dioxide, dry chemical, or water spray.
Toxic or corrosive gases including oxides of carbon, nitrogen, and sulfur products
are expected in fires involving this material.
SECTION 6 - ACCIDENTAL RELEASE MEASURES
Review Sections 3, 8 and 12 before proceeding with clean up.
Sweep spilled material into an approved container for disposal. Clean spillarea thoroughly. Prevent discharge to drains. Large spill
Contain the source of the spill or leak if it is safe to do so. Scoop or shovelspilled material into a labeled container for disposal. Clean spill areathoroughly. Prevent discharge to drains. SECTION 7 - HANDLING AND STORAGE
IF TABLETS OR CAPSULES ARE CRUSHED AND/OR BROKEN,AVOID BREATHING DUST AND AVOID CONTACT WITH EYES,SKIN AND CLOTHING.
Avoid prolonged storage at elevated temperatures (greater than roomtemperature, approximately 20 degrees C). Keep in tightly sealedcontainers in a well-ventilated area.
SECTION 8 - EXPOSURE CONTROLS/PERSONAL PROTECTION
Good general ventilation should be sufficient to control airborne levels.
Respirators are not required for normal use of this material.
Not required under normal conditions of use. Wear safety glasses orgoggles if eye contact is possible. Skin protection
Wear protective clothing with long sleeves to avoid routine skin contact. Wash hands and arms thoroughly after handling this material. Clean upspills immediately. Hand protection
Wear protective gloves to avoid routine skin contact.
SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES
SECTION 10 - STABILITY AND REACTIVITY
SECTION 10 - STABILITY AND REACTIVITY . continued
Conditions to avoid
Direct sunlight, conditions that might generate heat and dispersion as adust cloud Incompatibilities
SECTION 11 - TOXICOLOGY INFORMATION
Not determined for this mixture. May cause eye irritation based oncomponents.
Not determined for this mixture. Irritation may occur based on components.
Not determined for this mixture. However, allergic reactions might occurbased on effects of amoxicillin. Ingestion
Not determined for this mixture. The rat oral LD50 is expected to begreater than 2000 mg/kg based on toxicities of individual components andconcentrations present.
This mixture is not expected to be mutagenic, based on effects of individual components. Sensitization
Sensitization (allergic skin reaction) may occur, based on effects ofindividual components.
None of the components of this formulation is listed as a carcinogen byIARC, NTP or OSHA. Reproductive effects
Not determined for this mixture. Components in this mixture are unlikelyto produce reproductive effects in humans at levels encounteredoccupationally. SECTION 11 - TOXICOLOGY INFORMATION . continued
Not determined for this mixture. Components in this mixture are unlikelyto produce developmental effects in humans at levels encounteredoccupationally. At increased risk from
This mixture contains material that is a penicillin antibiotic.
SECTION 12 - ECOLOGICAL INFORMATION
Penicillins are susceptible to degradation by a number of microorganismsfound in wastewater treatment plants and the general environment.
Resulting degradation products are readily mineralized by environmentalmicroorganisms. SECTION 13 - DISPOSAL INFORMATION
Collect for recycling or recovery, if possible. Observe all local andnational regulations when disposing of this material. Dispose of materialon site in a licensed chemical incinerator, if allowed by the incineratorpermit. If no on-site incinerator is available, dispose of material in alicensed commercial chemical incinerator.
SECTION 14 - TRANSPORTATION INFORMATION
SECTION 15 - REGULATORY INFORMATION
EU Label Pictogram(s)
R42 - May cause sensitisation by inhalation. R43 - May cause sensitization by skin contact.
S22 - Do not breathe dust. S24 - Avoid contact with skin. S36/37 - Wear suitable protective clothing and gloves. SECTION 15 - REGULATORY INFORMATION . continued
This product has been classified in accordance with the hazard criteria ofthe CPR and the MSDS contains all of the information required by theCPR.
SECTION 16 - OTHER
Pfizer Inc believes that the information contained in this Material
Safety Data Sheet is accurate, and while it is provided in good faith, it
is without a warranty of any kind, expressed or implied.
MSN Home | My MSN | Hotmail | Shopping | Money | People & Chat Old wives' tales exposed Health & Wellness Do you know what health folklore is fact and what's fiction? At some point in your life, you realize that Mother mostly knows best, but some of the things she taught you over the years weren't exactly